Our Publications
Our publications
Preclinical and clinical validation of Eikonizo’s novel HDAC6 PET tracer
Translation of HDAC6 PET Imaging Using [18F]EKZ-001–cGMP Production and Measurement of HDAC6 Target Occupancy in Nonhuman Primates
[18F]EKZ-001 quantification methods were validated in nonhuman primates (NHP) and used to show that the novel compound EKZ-317 achieves high target occupancy in brain.
Read More
Clinical validation of the
novel HDAC6 radiotracer
[18F]EKZ-001 in the
human brain
[18F]EKZ-001 is safe and appropriate for quantifying HDAC6 expression in the human brain.
Read More
see our latest news
Look some News
June 2, 2020
Under the Microscope: Ludo Van Den Bosch on returning to work, exploring therapeutic strategies to battle ALS & FTD.
March 10, 2020
Women of the C-Suite: “Your career path might not always be linear,” With Janice Kranz, Ph.D. of Eikonizo Therapeutics
March 4, 2020
Nearly $4 Million In Research Funding For Promising New Treatments In Alzheimer’s And Other Dementia
If you feel something bother you, we are here to help you
Want to learn more?